Vancouver-based Absci valued at nearly $2 billion in IPO trading
Vancouver-based biotechnology firm Absci held an initial public offering Thursday, resulting in a valuation of nearly $2 billion. The news comes a little more than a year after the…
Vancouver-based biotechnology firm Absci held an initial public offering Thursday, resulting in a valuation of nearly $2 billion. The news comes a little more than a year after the…